COMMUNIQUÉS West-GlobeNewswire

Agile Therapeutics to Present Combined Safety Data from Three Phase 3 Studies at the 2019 ACOG Annual Meeting
03/05/2019
PRINCETON, N.J., May 03, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced that the combined safety data from three Phase 3 studies of Twirla ® (AG200-15), [...]
AMAG Pharmaceuticals Presents New Data at the American College of Obstetricians and Gynecologists Annual Meeting
03/05/2019
WALTHAM, Mass., May 03, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that it will present new data related to investigational drug bremelanotide for the treatment of hypoactive [...]
Real-World Evidence and Insights into gammaCore™ (nVNS) Mechanism of Action to be Presented at the American Academy of Neurology’s 71st Annual Meeting
03/05/2019
BASKING RIDGE, N.J., May 03, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that two oral presentations featuring non-invasive vagus nerve [...]
AlloMap In-Network with Anthem Blue Cross
03/05/2019
AlloMap now in-network for over 80% of covered lives with all US payors BRISBANE, Calif., May 03, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, [...]
Blissco Corporate Update
03/05/2019
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, May 03, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. ( CSE: BLIS ) ( OTCQB: HSTRF ) ( FRA: GQ4B ), (“Blissco”) or the (“Company”) is [...]
Idorsia holds its second Annual General Meeting of Shareholders - All Board proposals approved
03/05/2019
Allschwil, Switzerland - May 3, 2019 At today's Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders voted in favor of all proposals by the Board of Directors with a [...]
ADMA Biologics Elects to Draw-Down $27.5 Million in Capital from Existing Perceptive Advisors Credit Agreement
03/05/2019
Perceptive Advisors Provides Additional Funding Tranche Commitment of $12.5 Million Available Upon FDA Approval of BIVIGAM® RAMSEY, N.J. and BOCA RATON, Fla., May 03, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. ( [...]
Calithera Biosciences to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019
03/05/2019
SOUTH SAN FRANCISCO, Calif., May 03, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that [...]
The Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at the scientific conference "American Academy of Neurology - AAN" in Philadelphia, PA, on May 6 2019
03/05/2019
PRESS RELEASE Lund Sweden, May 3, 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease has been selected to be presented orally by [...]
Digirad Corporation Reports Financial Results for the First Quarter Ended March 31, 2019
03/05/2019
Performs within expectations, highlighted by DIS growth in revenue of 7% year over year Closed asset-based loan of $20 million with Sterling National Bank Made significant progress towards “HoldCo” transformation by [...]
Dentsply Sirona Reports Solid First Quarter 2019 Results
03/05/2019
Reported Q1 revenues of $946.2 million, declined 1.0% versus prior year and increased 3.9% on an internal sales growth basis. Q1 2019 US GAAP EPS of $0.17 vs. $0.35 in Q1 2018. Q1 2019 Non-US GAAP EPS of $0.49 compared [...]
HMS Reports First Quarter 2019 Financial Results
03/05/2019
Total Revenue of $148.0 Million, +4.7% vs. 1Q’18 (+11.3% excluding Medicare RAC Reserve Release in 1Q’18) GAAP EPS of $0.22 Per Diluted Share, Including Discrete Tax Benefits of $0.07 Per Diluted Share Adjusted EPS of $ [...]
Novo Nordisk's operating profit increased by 14% in Danish kroner and by 8% at constant exchange rates (CER) in the first three months of 2019
03/05/2019
Sales increased by 9% in Danish kroner and by 4% at CER to DKK 29.3 billion. Operating profit growth of 8% at CER was positively impacted by a reversal of write-downs of oral semaglutide prelaunch inventory. Sales in [...]
Nicox Presents First Data on Promising New Class of Nitric Oxide (NO)-Donating Compounds for Glaucoma at the ARVO 2019 Annual Meeting
03/05/2019
Press Release Nicox Presents First Data on Promising New Class of Nitric Oxide (NO)-Donating Compounds for Glaucoma at the ARVO 2019 Annual Meeting Nitric oxide (NO)-donating phosphodiesterase-5 (PDE5) inhibitors [...]
Nicox : Premières données d’une nouvelle classe prometteuse de donneurs d’oxyde nitrique (NO) pour le glaucome présentées au congrès ARVO 2019
03/05/2019
Communiqué de presse Nicox : Premières données d’une nouvelle classe prometteuse de donneurs d’oxyde nitrique (NO) pour le glaucome présentées au congrès ARVO 2019 Les donneurs d’oxyde nitrique (NO) inhibiteurs de la [...]
MDxHealth: Presentation of New Data for MDxHealth's Prostate Cancer Diagnostic Tests at AUA 2019 Annual Meeting
03/05/2019
PRESS RELEASE Moderated posters feature clinical validations of SelectMDx and ConfirmMDx IRVINE, CA, and HERSTAL, BELGIUM - MAY 3, 2019 - MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular [...]
MDxHealth (R) :
03/05/2019
Acacia Pharma Receives Complete Response Letter From Fda for Barhemsys®
03/05/2019
ACACIA PHARMA RECEIVES COMPLETE RESPONSE LETTER FROM FDA FOR BARHEMSYS ® This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge, UK and [...]
ObsEva SA Reports Consistent Long-Term Findings from Phase 2b EDELWEISS trial of Linzagolix for Endometriosis-Associated Pain
03/05/2019
Geneva, Switzerland and Boston, MA – May 3, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]

Pages